Avenue Short Term Debt vs Total Current Liabilities Analysis

ATXI Stock  USD 1.90  0.07  3.83%   
Avenue Therapeutics financial indicator trend analysis is way more than just evaluating Avenue Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Avenue Therapeutics is a good investment. Please check the relationship between Avenue Therapeutics Short Term Debt and its Total Current Liabilities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.

Short Term Debt vs Total Current Liabilities

Short Term Debt vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Avenue Therapeutics Short Term Debt account and Total Current Liabilities. At this time, the significance of the direction appears to have no relationship.
The correlation between Avenue Therapeutics' Short Term Debt and Total Current Liabilities is 0.09. Overlapping area represents the amount of variation of Short Term Debt that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Avenue Therapeutics, assuming nothing else is changed. The correlation between historical values of Avenue Therapeutics' Short Term Debt and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Debt of Avenue Therapeutics are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Short Term Debt i.e., Avenue Therapeutics' Short Term Debt and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.09
Relationship DirectionPositive 
Relationship StrengthInsignificant

Short Term Debt

Total Current Liabilities

Total Current Liabilities is an item on Avenue Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Avenue Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Avenue Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Avenue Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.The Avenue Therapeutics' current Issuance Of Capital Stock is estimated to increase to about 7.9 M, while Selling General Administrative is projected to decrease to under 3.3 M.

Avenue Therapeutics fundamental ratios Correlations

0.480.210.00.940.920.51-0.87-0.20.530.951.00.130.18-0.46-0.520.350.38-0.340.091.00.520.10.0-0.14-0.11
0.480.490.050.590.620.99-0.69-0.780.230.580.460.70.23-0.97-0.720.80.84-0.51-0.30.480.990.67-0.07-0.71-0.77
0.210.490.210.270.260.5-0.51-0.610.030.430.190.520.7-0.51-0.390.580.61-0.22-0.140.210.50.610.01-0.63-0.6
0.00.050.21-0.26-0.280.090.210.370.42-0.07-0.03-0.510.03-0.060.42-0.38-0.390.770.180.00.09-0.370.570.40.32
0.940.590.27-0.261.00.6-0.95-0.490.40.930.940.390.17-0.6-0.730.620.62-0.64-0.160.940.60.33-0.17-0.42-0.38
0.920.620.26-0.281.00.62-0.94-0.510.390.920.920.420.13-0.62-0.750.640.65-0.66-0.190.920.620.38-0.18-0.43-0.4
0.510.990.50.090.60.62-0.71-0.750.250.620.490.680.3-0.96-0.70.770.82-0.48-0.220.511.00.63-0.04-0.69-0.74
-0.87-0.69-0.510.21-0.95-0.94-0.710.63-0.36-0.95-0.86-0.54-0.380.690.74-0.73-0.760.660.11-0.87-0.71-0.470.110.590.55
-0.2-0.78-0.610.37-0.49-0.51-0.750.630.11-0.41-0.2-0.9-0.330.820.8-0.99-0.970.820.55-0.2-0.74-0.860.330.980.97
0.530.230.030.420.40.390.25-0.360.110.350.47-0.38-0.23-0.230.21-0.01-0.030.10.040.530.25-0.340.80.210.02
0.950.580.43-0.070.930.920.62-0.95-0.410.350.950.370.39-0.56-0.650.530.58-0.460.070.950.620.3-0.12-0.38-0.31
1.00.460.19-0.030.940.920.49-0.86-0.20.470.950.150.18-0.44-0.550.340.38-0.350.081.00.50.11-0.07-0.14-0.09
0.130.70.52-0.510.390.420.68-0.54-0.9-0.380.370.150.43-0.67-0.790.870.92-0.78-0.30.130.670.93-0.52-0.92-0.87
0.180.230.70.030.170.130.3-0.38-0.33-0.230.390.180.43-0.18-0.280.290.41-0.130.430.180.310.39-0.19-0.46-0.33
-0.46-0.97-0.51-0.06-0.6-0.62-0.960.690.82-0.23-0.56-0.44-0.67-0.180.75-0.85-0.840.550.46-0.46-0.96-0.640.10.750.79
-0.52-0.72-0.390.42-0.73-0.75-0.70.740.80.21-0.65-0.55-0.79-0.280.75-0.85-0.840.790.45-0.52-0.69-0.740.660.760.65
0.350.80.58-0.380.620.640.77-0.73-0.99-0.010.530.340.870.29-0.85-0.850.97-0.86-0.550.350.770.81-0.31-0.95-0.94
0.380.840.61-0.390.620.650.82-0.76-0.97-0.030.580.380.920.41-0.84-0.840.97-0.83-0.380.380.820.87-0.31-0.94-0.93
-0.34-0.51-0.220.77-0.64-0.66-0.480.660.820.1-0.46-0.35-0.78-0.130.550.79-0.86-0.830.46-0.34-0.48-0.650.440.80.76
0.09-0.3-0.140.18-0.16-0.19-0.220.110.550.040.070.08-0.30.430.460.45-0.55-0.380.460.09-0.2-0.40.250.430.46
1.00.480.210.00.940.920.51-0.87-0.20.530.951.00.130.18-0.46-0.520.350.38-0.340.090.520.10.0-0.14-0.11
0.520.990.50.090.60.621.0-0.71-0.740.250.620.50.670.31-0.96-0.690.770.82-0.48-0.20.520.63-0.04-0.69-0.74
0.10.670.61-0.370.330.380.63-0.47-0.86-0.340.30.110.930.39-0.64-0.740.810.87-0.65-0.40.10.63-0.49-0.83-0.81
0.0-0.070.010.57-0.17-0.18-0.040.110.330.8-0.12-0.07-0.52-0.190.10.66-0.31-0.310.440.250.0-0.04-0.490.360.13
-0.14-0.71-0.630.4-0.42-0.43-0.690.590.980.21-0.38-0.14-0.92-0.460.750.76-0.95-0.940.80.43-0.14-0.69-0.830.360.96
-0.11-0.77-0.60.32-0.38-0.4-0.740.550.970.02-0.31-0.09-0.87-0.330.790.65-0.94-0.930.760.46-0.11-0.74-0.810.130.96
Click cells to compare fundamentals

Avenue Therapeutics Account Relationship Matchups

Avenue Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets8.9M3.2M4.0M6.8M1.9M1.8M
Other Current Liab1.7M714K147K3.4M795K1.1M
Total Current Liabilities2.1M886K509K3.6M1.2M2.2M
Total Stockholder Equity6.8M2.4M3.5M3.9M1.6M2.9M
Net Tangible Assets(631K)6.8M2.4M3.5M4.0M2.8M
Net Debt(8.7M)(3.1M)(3.8M)(6.7M)(1.8M)(1.9M)
Retained Earnings(68.1M)(73.3M)(77.0M)(80.6M)(90.9M)(86.4M)
Accounts Payable368K172K362K150K401K778.9K
Cash8.7M3.1M3.8M6.7M1.8M1.7M
Cash And Short Term Investments8.7M3.1M3.8M6.7M1.8M1.7M
Common Stock Shares Outstanding1.0M1.1M1.1M2.2M141.2K134.2K
Liabilities And Stockholders Equity8.9M3.2M4.0M6.8M1.9M1.8M
Non Current Liabilities Total0.03.6M368K172K362K949.0
Capital Surpluse38.9M41.6M74.9M75.6M87.0M91.3M
Other Stockholder Equity74.9M75.6M80.4M84.5M92.5M59.9M
Total Liab2.1M886K509K3.6M1.2M1.1M
Total Current Assets8.9M3.2M4.0M6.8M1.9M1.8M
Other Assets1.9M170K113K137.067K63.7K
Other Current Assets170K113K107K137K67K129.6K
Net Invested Capital6.8M2.4M3.5M3.9M1.6M1.5M
Net Working Capital6.8M2.4M3.5M3.3M654K621.3K

Currently Active Assets on Macroaxis

When determining whether Avenue Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avenue Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avenue Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avenue Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avenue Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avenue Therapeutics. If investors know Avenue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avenue Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Earnings Share
24.78
Return On Assets
(2.01)
Return On Equity
(5.35)
The market value of Avenue Therapeutics is measured differently than its book value, which is the value of Avenue that is recorded on the company's balance sheet. Investors also form their own opinion of Avenue Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Avenue Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avenue Therapeutics' market value can be influenced by many factors that don't directly affect Avenue Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avenue Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avenue Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avenue Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.